Amylyx Pharmaceuticals Inc
NASDAQ:AMLX 12:56:12 AM EDT
Amylyx Pharmaceuticals Inc Stock, NASDAQ:AMLX
43 Thorndike Street, Cambridge, Massachusetts 02141
United States of America
Phone: +1.617.682.0917
Number of Employees: 123
Description
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.